You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

glutamate antagonist

Showing 1 - 25 of 2,134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)

Recruiting
  • Rotator Cuff Tendinitis
  • Chronic Pain
  • Kristiansund, Norway
    Department of Orthopedic Surgery, Kristiansund Hospital
Mar 15, 2022

Disorder of Glucose Regulation Trial in Bergholz-Rehbrücke (sweet block, bitter block, umami-block)

Completed
  • Disorder of Glucose Regulation
  • sweet block
  • +3 more
  • Bergholz-Rehbrücke, Brandenburg, Germany
    Department of Clinical Nutrition
Jun 23, 2020

Depression Trial in Atlanta (Infliximab, Placebo)

Active, not recruiting
  • Depression
  • Atlanta, Georgia
    Emory University
Jan 23, 2023

Treatment Resistant Depression, Depression, MDD Trial in Oxford (Ketamine Hydrochloride, No intervention ())

Recruiting
  • Treatment Resistant Depression
  • +2 more
  • Ketamine Hydrochloride
  • No intervention (placebo)
  • Oxford, United Kingdom
    Department of Psychiatry, University of Oxford
Mar 28, 2023

Magnetic Resonance Imaging, Major Depression, Alcoholism Trial in Iowa City (Ketamine, Alcohol Infusion)

Recruiting
  • Magnetic Resonance Imaging
  • +2 more
  • Iowa City, Iowa
    University of Iowa Health Care
Aug 25, 2022

Cocaine Use Disorder, Cocaine Dependence Trial in Zürich (Ketamine, Placebo, real-time fMRI neurofeedback training)

Not yet recruiting
  • Cocaine Use Disorder
  • Cocaine Dependence
  • Zürich, Switzerland
    Psychiatric University Hospital Zurich, University of Zurich
Nov 6, 2023

Drug-resistant Psychiatric Disorders Using Induced Pluripotent

Enrolling by invitation
  • Depressive Disorder, Treatment-Resistant
    • Monza, Monza E Brianza, Italy
      Fondazione IRCCS San Gerardo di Monza
    May 24, 2023

    MDD, Treatment-Resistant Depression, Depression Trial run by the NIMH (Placebo, TS-161 (50 - 100 mg))

    Recruiting
    • Major Depressive Disorder
    • +2 more
    • Placebo
    • TS-161 (50 - 100 mg)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Psychosis, Negative Symptoms With Primary Psychotic Disorder Trial in Glostrup (Memantine, Placebo)

    Recruiting
    • Psychosis
    • Negative Symptoms With Primary Psychotic Disorder
    • Glostrup, Capitol Region, Denmark
      Centre for Neuropsychiatric Schizophrenia Research, CNSR & Centr
    Aug 23, 2021

    Autism Spectrum Disorder Trial in Columbia (Memantine, Magnetic Resonance Imaging)

    Completed
    • Autism Spectrum Disorder
    • Columbia, Missouri
      University of Missouri
    Apr 9, 2021

    Preemptive Analgesia, Dexmedetomidine, Ketamine Trial in Kafr Ash Shaykh (Dexmedetomidine, Ketamine, Magnesium sulphate)

    Not yet recruiting
    • Preemptive Analgesia
    • +5 more
    • Kafr Ash Shaykh, Karelsheikh, Egypt
      Karelsheikh University Hospital
    Apr 19, 2023

    Familial Alcoholism Vulnerability Trial in Hartford (Mavoglurant (AFQ056), Placebo)

    Completed
    • Familial Alcoholism Vulnerability
    • Mavoglurant (AFQ056)
    • Placebo
    • Hartford, Connecticut
      Hartford Hospital
    Jan 7, 2022

    Schizophrenia Spectrum and Other Psychotic Disorders Trial in New York (Risperidone)

    Recruiting
    • Schizophrenia Spectrum and Other Psychotic Disorders
    • New York, New York
      New York State Psychiatric Institute & Columbia University
    Jul 28, 2022

    MDD, Excessive Sleepiness Trial in Eatontown (GATE-101)

    Terminated
    • Major Depressive Disorder
    • Excessive Sleepiness
    • Eatontown, New Jersey
      Clinilabs Drug Development Corporation
    Aug 1, 2022

    Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T

    Recruiting
    • Gilles de la Tourette Syndrome
    • Tourette Syndrome
    • MRI scanner (7 Tesla)
    • Leipzig, Germany
      Max Planck Institute for Human Cognitive and Brain Sciences
    Feb 10, 2022

    OCD Trial (Memantine Oral Tablet, Placebo)

    Not yet recruiting
    • Obsessive-Compulsive Disorder
    • Memantine Oral Tablet
    • Placebo
    • (no location specified)
    Aug 19, 2021

    Pathophysiology of Gilles de la Tourette Syndrome. Part 1:

    Not yet recruiting
    • Gilles de la Tourette Syndrome
    • Tourette Syndrome
    • PET/MR scanner
    • Leipzig, Germany
      Max Planck Institute for Human Cognitive and Brain Sciences
    Feb 11, 2022

    Episiotomy Wound, Pain, Procedural Trial (Magnesium sulfate)

    Not yet recruiting
    • Episiotomy Wound
    • Pain, Procedural
    • Magnesium sulfate
    • (no location specified)
    Jun 9, 2022

    Refractory Epilepsy Trial in Birmingham (Traditional Treatment (Group T), Ketamine Infusion (Group K))

    Withdrawn
    • Refractory Epilepsy
    • Traditional Treatment (Group T)
    • Ketamine Infusion (Group K)
    • Birmingham, Alabama
      UAB Department of Anesthesiology and Perioperative Medicine
    May 18, 2021

    Alcoholism Trial in West Haven (Ketamine and Placebo)

    Completed
    Has Results
    • Alcoholism
    • Ketamine and Placebo
    • West Haven, Connecticut
      VA Connecticut Healthcare System
    Sep 9, 2021

    OCD Trial in Stanford (Ketamine, Midazolam)

    Active, not recruiting
    • Obsessive-Compulsive Disorder
    • Stanford, California
      Stanford University
    May 24, 2022

    Cancer Pain, Adenocarcinoma Trial in Ottawa (Methadone, Morphine)

    Withdrawn
    • Cancer Pain
    • Adenocarcinoma
    • (no location specified)
    Dec 1, 2022

    Borderline Personality Disorder Trial (Caplyta, Placebo)

    Not yet recruiting
    • Borderline Personality Disorder
    • (no location specified)
    May 16, 2022

    MDD, Treatment Resistant Depression Trial in Chicago, Melbourne (Nitrous oxide gas for inhalation, Placebo)

    Recruiting
    • Major Depressive Disorder
    • Treatment Resistant Depression
    • Nitrous oxide gas for inhalation
    • Placebo
    • Chicago, Illinois
    • +1 more
    Dec 21, 2022

    Psychosis, Schizophrenia, Schizoaffective Disorder Trial in New York (ceftriaxone, Normal Saline)

    Terminated
    Has Results
    • Psychosis
    • +2 more
    • New York, New York
      NYS Psychiatric Institute
    Dec 14, 2021